PLoS ONE (Jan 2021)

Can follow up lung ultrasound in Coronavirus Disease-19 patients indicate clinical outcome?

  • Tatjana Hoffmann,
  • Peter Bulla,
  • Lisa Jödicke,
  • Constantin Klein,
  • Sarah M Bott,
  • Ronald Keller,
  • Nisar Malek,
  • Eckhart Fröhlich,
  • Siri Göpel,
  • Gunnar Blumenstock,
  • Stefano Fusco

DOI
https://doi.org/10.1371/journal.pone.0256359
Journal volume & issue
Vol. 16, no. 8
p. e0256359

Abstract

Read online

PurposeTo evaluate whether there is a change in findings of coronavirus disease 2019 patients in follow up lung ultrasound and to determine whether these findings can predict the development of severe disease.Materials and methodsIn this prospective monocentric study COVID-19 patients had standardized lung ultrasound (12 area evaluation) at day 1, 3 and 5. The primary end point was detection of pathologies and their change over time. The secondary end point was relationship between change in sonographic results and clinical outcome. Clinical outcome was assessed on development of severe disease defined as need for intensive care unit.ResultsData of 30 patients were analyzed, 26 patients with follow-up lung ultrasound. All of them showed lung pathologies with dynamic patterns. 26,7% developed severe disease tending to have an ubiquitous lung involvement in lung ultrasound. In patients with need for intensive care unit a previously developed increase in B-lines, subpleural consolidations and pleural line irregularities was more common. A statistically significant association between change in B-lines as well as change in pleural line irregularities and development of severe disease was observed (pConclusionThe present study demonstrates that follow up lung ultrasound can be a powerful tool to track the evolution of disease and suggests that lung ultrasound is able to indicate an impending development of severe disease in COVID-19 patients.